BlackRock, Inc. - Jan 31, 2025 Form SCHEDULE 13G/A Schedule Report for Vanda Pharmaceuticals Inc. (VNDA)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Vanda Pharmaceuticals Inc. Common Stock
Symbol: VNDA
Shares outstanding: 58M shares
Disclosed Ownership: 4.7M shares
Ownership: 8.1%
Form type: SCHEDULE 13G/A
Date filed: 2/7/2025, 01:40 PM
Date of event: Jan 31, 2025
Previous filing: Feb 5, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	8.1%	4.7M	4.62M	0	Spencer Fleming	Managing Director